SPRY

ARS Pharmaceuticals, Inc.
3.05 -9.76% 2026-11-02
52-week range
2.91 13.15
1-month-25.1%
3-month-42.7%
1-year-64.6%
3-year-13.4%
5-year-66.2%
vs 50-day-32.6%
vs 200-day-58.5%
Volatility75%
Beta1.60
$ vol/day$7M
ATH63.41
From ATH-95.2%
Next report2026-11-05
Nothing written about SPRY yet. Be the first — call it long or short with an entry we price for you, or post a neutral write-up that takes no side. Create a free account
2026AprJulOct

bought sold · bigger dot, bigger trade · follows the chart’s range

WhenPeople SizeValuePrice
5mo sched 2 $283,550 9.91
12mo sell 2 $1,665,749 8.43
1.2y sched 2 $912,000 14.21
1.2y sched 1 $703,759 14.70
1.3y sched 1 $254,850 16.48
1.3y sell 1 $13,663,151 16.70
1.4y sched 1 $240,000 15.78
1.5y sell 3 $3,866,863 14.30
1.6y sched 1 $615,025 12.72
1.6y sched 1 $140,000 13.25
1.7y sched 1 $560,416 10.81
1.7y sched 1 $615,500 12.23
1.8y sched 1 $555,000 11.14
1.9y sched 2 $2,334,000 11.13
1.9y sell 1 $1,768,576 12.21
1.9y sched 1 $493,950 12.21
1.9y sell 1 $657,500 12.30
1.9y sched 2 $2,633,000 12.61
1.9y sell 1 $2,040,663 14.22
1.9y sell 1 $1,208,700 13.92
1.9y sched 2 $2,828,560 13.92
1.9y sell 1 $1,411,859 14.53
2.0y sched 2 $2,790,000 13.38
2.0y sched 2 $3,369,303 14.62
2.0y sell 1 $10,143,706 15.16
2.0y sched 3 $3,175,131 16.43
2.1y sched 2 $2,766,000 13.61
2.1y sched 3 $2,726,000 14.61
2.1y sched 2 $2,300,000 12.33
2.2y sell 2 $2,176,070 13.90
2.2y sell 2 $22,995,926 13.00
2.2y sched 5 $4,095,443 14.12
2.2y sched 3 $2,885,112 13.32
2.3y sched 2 $2,280,000 10.88
2.3y sched 2 $1,924,000 10.89
2.4y sched 2 $1,827,798 9.02
2.5y sched 2 $1,811,266 8.96
2.5y sched 2 $1,868,000 8.96
2.5y sched 2 $1,856,000 9.08
2.6y sched 2 $1,856,000 9.22
2.6y buy 1 $13,289,410 9.93
2.6y sched 2 $1,779,932 9.66
2.6y sched 2 $43,154 8.85
2.6y sched 2 $1,827,092 9.12
2.7y sched 2 $68,188 8.64
2.7y sched 2 $1,794,569 9.01
3.1y buy 1 $319,655 3.85
3.1y buy 1 $8,183,526 3.74
3.2y sched 1 $771,000 7.19
3.2y buy 3 $29,450,000 7.08
3.2y sched 1 $316,423 6.93
3.3y sched 1 $391,793 6.99
3.3y sell 1 $56,337 6.33
3.3y sell 1 $590,361 6.27
3.4y sched 1 $684,041 7.06
3.5y sched 1 $780,579 4.59
3.9y buy 1 $51,480 6.33

Next report 2026-11-05 (Thursday, after close, in 3 days) · EPS estimate -0.33. It has finished the next session higher 20% of the time, average move 6.0%.

Day-after move, last 12 reports, oldest left.

ReportedEst.Actual SurpriseGapDay 1Day 5
2026-08-13 miss -0.49 -0.63 -27.7% -16.4% -7.4% -9.8%
2026-05-15 miss -0.53 -0.61 -14.0% -6.8% -6.5% +0.0%
2026-03-09 beat -0.48 -0.42 +12.5% +3.1% -0.1% -4.0%
2025-11-10 miss -0.49 -0.52 -6.1% +13.0% +0.3% -17.3%
2025-08-13 beat -0.51 -0.46 +10.7% -1.0% -5.0% -12.4%
2025-05-14 beat -0.36 -0.35 +3.5% -8.2% -9.4% +6.5%
2025-03-20 beat -0.12 0.51 +534.0% +5.6% +22.8% +8.4%
2024-11-13 miss -0.14 -0.20 -42.9% -3.0% -15.2% -18.4%
2024-08-06 miss -0.11 -0.13 -13.0% -1.0% -2.2% +32.9%
2024-05-09 -0.11 -0.11 — +1.5% -0.7% +2.6%
2024-03-21 beat -0.12 -0.07 +44.0% +0.0% -3.9% +5.2%
2023-11-09 beat -0.18 -0.16 +11.1% +4.4% +8.7% +37.3%
2023-08-10 miss -0.16 -0.18 -9.1% -0.6% -0.3% -2.5%
2023-05-15 miss -0.15 -0.16 -3.2% +0.9% -2.9% +13.1%
2023-03-23 beat -0.12 -0.09 +25.0% -0.4% -4.0% -17.7%
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+1.3%
Next 1 week
+1.6%
Next 1 month
+4.0%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 1
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.57%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.60 +3.9% · Seasonal tilt (5y) +0.1%
$7M/day volume 75% volatility -65% 1-year
52-week range · 1% of the way up · -77% from the high
$2.91$13.15

Not investment advice.